FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

764774009: Conventional release and prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3655031016 Conventional release and prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3655032011 Conventional release and prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release and prolonged-release oral tablet Is a Prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Is a Conventional release oral tablet true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Has dose form release characteristic Conventional release and prolonged-release true Inferred relationship Existential restriction modifier
Conventional release and prolonged-release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nicotinic acid 750 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 1 gram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely etoricoxib 90 milligram and thiocolchicoside 8 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and metoprolol tartrate (as metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start